Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    HM74A/PUMA-G/GPR109A/NIACR1 Antibody (245106), DyLight 350, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rat Monoclonal Antibody
Supplier: Novus Biologicals FAB2760D
                        
                            
                        
                        
                        
                            
                        
                        
                        
                        
                            
                                    
                                This item is not returnable.
                                View return policy
                                
                        
                    
                Description
HM74A/PUMA-G/GPR109A/NIACR1 Monoclonal antibody specifically detects HM74A/PUMA-G/GPR109A/NIACR1 in Human samples. It is validated for Flow CytometrySpecifications
| HM74A/PUMA-G/GPR109A/NIACR1 | |
| Monoclonal | |
| DyLight 350 | |
| GPR109A, HCA2, hydroxycarboxylic acid receptor 2, NIACR1 | |
| NS0 mouse myeloma cell line transfected with human HM74A/GPR109A, Met1-Pro363, Accession # Q8TDS4 | |
| 0.5 mL | |
| GPCR | |
| 338442 | |
| Store at 4°C in the dark. | |
| IgG2b | 
| Flow Cytometry | |
| 245106 | |
| 50mM Sodium Borate | |
| Rat | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| Primary | |
| Human | |
| Purified | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction